24
Feb 2026
Eating unhealthy foods early in life leave lasting brain and feeding changes but gut bacteria can help restore healthy eating, new University College Cork (UCC) research study finds today (Tuesday 24th February 10am)
24
Feb 2026
When cancer-driving proteins resist various treatments, Northwestern University scientists have uncovered a new solution. Don't fight them - throw them in the cellular trash.
24
Feb 2026
UV26DCMed is a one-component adhesive system designed for medical device assembly, offering dual curing and compatibility with various sterilization methods.
24
Feb 2026
The SCREESCO trial reveals that colorectal cancer screening at 60 enhances early diagnosis without affecting overall mortality or increasing long-term risks.
24
Feb 2026
In Switzerland, 0.02% of the population lives beyond the age of 100. Could there be biological characteristics associated with this exceptional longevity? As part of the "SWISS100" study, the first large-scale Swiss research project dedicated to centenarians, a team from the University of Geneva (UNIGE) and the University of Lausanne (UNIL) compared the blood profiles of centenarians with those of octogenarians, and then with those of individuals aged 30 to 60.
24
Feb 2026
Older people who are physically active have a significantly lower risk of developing sarcopenic obesity - a combination of obesity and weak muscles.
24
Feb 2026
A research team led by the University of Waterloo is developing a novel tool to treat cancer by engineering hungry bacteria to literally eat tumors from the inside out.
24
Feb 2026
Bruker Corporation today announced new advancements to enable Functional Proteomics 2.0 workflows on the timsOmni™ mass spectrometer to enable disease researchers to move beyond canonical protein lists toward biologically or pathologically functional proteoforms and PTM-resolved peptide variants.
24
Feb 2026
Advantech, a global leader in embedded and Internet of Things (IoT) solutions, will showcase its latest healthcare AI innovations at the HIMSS 2026 Global Health Conference & Exhibition, March 9–12, 2026, in Las Vegas, Nevada.
_6e98296023b34dfabc133638c1ef5d32-620x480.jpg "SwRI advances safer manufacturing of nerve agent antidotes")
24
Feb 2026
Southwest Research Institute (SwRI) continues to expand its unique drug synthesis capabilities and expertise to advance the scalable manufacturing of safer antidotes to combat exposure to organophosphorus nerve agents (OPNAs) and pesticides.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
